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Health research involving child participants is essential to
develop appropriate interventions promoting their welfare.
Preventive research is of increasing importance, including the
development of childhood vaccines against HIV.1 Currently in
South Africa there are no laws regulating the rights of research
participants in research. Research ethics committees (RECs)
generally rely on ethical guidelines and to some extent
constitutional and common law.  The National Health Act
2
(hereafter referred to as ‘the Bill’), which has been passed and
is soon to be implemented, is the first attempt by the
legislature to use the law to regulate the rights of research
participants, including children. 
The South African National Health Act,
Section 71
Section 71 of the Act comprises three parts. Section 71(1)
contains general provisions regulating consent of all research
participants. It states that research or experimentation on a
living person may only be conducted in accordance with
regulations issued by the Minister of Health, with the written
consent of the person and provided that s/he has been advised
of the objectives of the research and any possible negative or
positive health consequences. 
Sections 71(2) and (3) contain additional provisions for
research involving minors. The sections state the following.
Section 71(2): Where research or experimentation is to be
conducted on a minor for therapeutic purposes, the research or
experimentation may only be conducted: (i) if it is in the best
interests of the minor; (ii) in such manner and on such
conditions as may be prescribed; (iii) with the consent of the
parent or guardian of the child; and (iv) if the minor is capable
of understanding, with the consent of the minor.
Section 71(3)(a): Where research or experimentation is to be
conducted on a minor for a non-therapeutic purpose, the
research or experimentation may only be conducted: (i) in such
manner and on such conditions as may be prescribed; (ii) with
the consent of the Minister; (iii) with the consent of the parent
or guardian of the minor; and (iv) if the minor is capable of
understanding, with the consent of the minor.
Section 71(3)(b): The Minister may not give consent in
circumstances where: (i) the objects of the research or
experimentation can also be achieved if it is conducted on an
adult; (ii) the reasons for the consent to the research or
experimentation are not likely to improve scientific
understanding of the minor’s condition, disease or disorder
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significantly to such an extent that it will result in significant
benefit to the minor or other minors; (iii) the reasons for the
consent to the research or experimentation by the parent or
guardian and, if applicable, the minor are contrary to public
policy; and (iv) the research or experimentation poses a
significant risk to the health of the minor, or there is some risk
to the health or wellbeing of the minor and the potential
benefit of the research or experimentation does not
significantly outweigh that risk. 
Strengths of Section 71 of the National
Health Act
Section 71 may appropriately strengthen protections for
research participants in the following ways. 
1. It establishes a platform for developing a wide range of
legal norms for human subjects research. Section 71(1)
empowers the Minister of Health to issue regulations
containing procedural and substantive safeguards for research
participants. For example, detailed provisions for ensuring
voluntary and informed consent could be developed in the
regulations, including the extent to which researchers should
inform participants of risks and benefits, and procedures for
assessing understanding, and recording participant decisions.  
2. It supplements and strengthens the existing general legal
principles relating to informed consent. Currently, for example,
common law personality rights, such as the right to physical
integrity, protect a person from being medically treated without
consent.3 However, there are no statutory laws or precedents
dealing explicitly with consent to medical research.4 Section
71(1) requires written consent for research and also gives
guidance regarding who should consent for child participation.  
3.  Section 71(2) introduces the concept of the ‘best interests’
of the child when research for a ‘therapeutic purpose’ is being
considered. This principle, although undefined, is well
established in South African divorce jurisprudence5,6 and is
considered of paramount importance in all matters concerning
the child as reflected in Section 28(2) of our Constitution.
South African courts have generally held that this means a
wide range of factors must be considered to promote a child’s
physical, moral, emotional and spiritual welfare.5 Section 6 of
the draft South African Children’s Bill7 sets out factors for a
best interests analysis. These include among others, the child's
age, needs, gender, background, maturity and stage of
development; physical and emotional security; intellectual,
emotional, socio-cultural development; and the need to protect
the child from physical and psychological harm. A further
significant factor is the view or opinion of the child.5 These
factors may be equally useful to guide decision-making
regarding child research participation. 
4. Section 71(3)(a)(ii) creates an additional procedural
safeguard for children participating in research with ‘a non-
therapeutic purpose’ by providing that the Minister of Health
must consent to the conduct of such research. The Minister of
Health’s discretion to approve such research is limited by four
factors set out in section 71(3)(b)(i) - (iv). These factors include
protectionist principles, a risk-benefit analysis, public policy,
and a risk standard. The term public policy means that the
research should not be contrary to the values that underlie the
constitution such as dignity and the promotion of human
rights.8 The presence of these principles is consistent with the
Constitutional Court’s9 finding that legislation according
discretionary powers to public officials should be drafted so as
to limit the risk of unconstitutional exercise of those powers. 
Limitations of the National Health Act,
Section 71
Section 71 of the Act is limited in the following ways: 
1.  It does not set an age for independent consent to medical
research. 
2.  It focuses on informed consent as the primary protection
for trial participants, omitting other protections such as right to
dignity, risk-benefit analyses and confidentiality.
3.  It may be inconsistent with existing and proposed
legislation on consent, e.g.:
• Section 71(2) requires consent from both the parent/
guardian and the child, regardless of age, for therapeutic
research. It does not distinguish between minors over and
under the age of 14 years.10 Such distinctions are maintained
in other legislation, such as Section 39 of the Child Care Act
(and in the draft Children’s Bill — the Department of Social
Development intends to repeal the existing Child Care Act
and replace it with the Children’s Bill), which allow a child
of 14 years to consent independently to ‘medical treatment’.
Some scholars argue that by implication, children may be
able to give independent consent to take part in research
defined as ‘therapeutic’.4 This section of the Act may, of
course, be interpreted as requiring the consent of the minor
and the assent of the parents (P Carstens — personal
communication, 8 November 2003).  
• Section 71(2) allows for children to consent to research
participation only if they are ‘capable of understanding’.
This is inconsistent with Section 43 of the Children’s Bill,
which provides that any major decisions involving a child
must give due consideration to any views and wishes
expressed by the child, bearing in mind the child’s age,
maturity and stage of development.  In other words in
terms of the Children’s Bill a child’s views must be
considered even if s/he is not fully capable of
understanding the research.
• Sections 71(2) and (3) state that consent must be provided
by ‘the parent or guardian’ of the minor. According to the
current Child Care Act and Criminal Procedure Act, a
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person who has been given custody of a child may consent
to medical treatment or an operation, instead of the parent
or guardian, unless the procedure poses a danger to life.11
According to Section 129(2)(b)(ii) of the proposed Children's
Bill, the primary caregiver may consent to any medical
treatment or operations where the child is under the age of
12 years, or incapable of understanding the treatment or
operation. In the face of inconsistencies between the Act and
the Children’s Bill it is unclear which will prevail as both
provide that in the event of a conflict they will override
other law.
• The Act may be inconsistent with existing national ethical
guidelines, e.g. the Act's risk standard for ‘non-therapeutic’
research is that of not ‘significant’ whereas the Medical
Research Council guidelines12 risk standard for ‘non-
therapeutic’ research is ‘negligible’ — a risk so small it may
be ignored. 
4. The Act retains the controversial distinction between
therapeutic and non-therapeutic research that has been
abandoned by many ethical guidelines, e.g. the Council of the
International Organisations of Medical Sciences (CIOMS) and
national law.13 This classification is problematic as most
research involves some interventions that are not intended to
confer direct health-related benefit (e.g. randomisation to
placebo). Furthermore, the Act does not define these terms. 
5. The Act does not describe the process for obtaining the
consent of the Minister for non-therapeutic research.
Presumably this will be detailed in regulations. It has been
submitted that the Minister may delegate this power to any
person acting in terms of the Act.10
6.  Poor drafting and inconsistencies impede interpretation of
the section.  For example: (i) Section 71(2) requires that a child's
‘best interests’ be considered when approving therapeutic
research, yet no such obligation is created for non-therapeutic
research; (ii) while a risk standard is described for non-
therapeutic research (Section 71(3)(a)(iv)), no risk standard is
described for therapeutic research; (iii) Section 71(3)(b)(ii)
implies that non-therapeutic research involves minors with an
existing medical condition, making it difficult to classify
research with healthy minors that may not confer direct health-
related benefit (such as phase I trials); and (iv) the terms
‘minor’ and ‘child’ are used interchangeably, when in fact
existing law considers minors to be persons below the age of 21
years, and children to be below the age of 18 years.14,15
Implications for researchers
Section 71 will have various implications for researchers,
including the following:
1.  It provides a specific legal basis for the participation of
minors in research including so-called non-therapeutic
research, unlike certain current ethical guidelines that restrict
non-therapeutic research on minors to observational research of
negligible risk.12 
2.  Research that is classified as either therapeutic or non-
therapeutic research will require additional procedures.
• In the case of research classified as therapeutic, researchers
may not be able to obtain independent consent from
children 14 years and older, but will also need parental
consent or assent. This means researchers will be faced with
the logistical and practical problems of securing consent
where parents or legal guardians are deceased or absent (for
example, child-headed households).
• In the case of non-therapeutic research, researchers are
obliged to obtain authorisation from the Minister before
proceeding. This may be a cumbersome and bureaucratic
process. 
• In obtaining consent from children, researchers will have to
identify children’s ability to understand the consent process.
Assessing understanding is a complex issue.16
Implications for RECs
Sections 71(2) and (3) will create various obligations for RECs
assessing and approving research protocols involving children,
including the following. 
1. RECs will have to categorise research protocols involving
minors as therapeutic or non-therapeutic despite some
conceptual problems and lack of definition. They will have to
be aware of the temptation of researchers to classify their
research as therapeutic as the standard for such research is
more relaxed.
2. RECs will need to ensure that consent procedures in all
protocols include mechanisms to involve parents and
guardians. 
3. RECs will also have to ensure that protocols stipulate how
it will be determined whether children have sufficient
understanding to consent jointly with their parents or
guardians to the research.
4. Finally, RECs will need to develop an understanding of the
new concepts such as the ‘best interests’ of the child, and
public policy considerations. 
Conclusions and recommendations
The Act is an important attempt to develop legal norms and
standards regarding the participation of children in research. It
fills a legal vacuum that has bedevilled children’s law. However
in many respects the Act fails to meet its objectives, in part
because of poor drafting and a failure to link with existing legal
principles and processes.  Its ability to protect children and
guide researchers and RECs may depend largely on the content
of the regulations to be enacted in terms of the Act.
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It is recommended that: (i) Section 71 of the National Health
Act should be amended to be more consistent with the
prevailing legislation; (ii) poor drafting and inconsistencies in
the Section should be corrected; (iii) the ideal placement of the
provisions should be reconsidered to determine whether they
are best placed within health or children's legislation; (iv)
regulations should provide details for substantive and
procedural safeguards to protect the rights of trial participants
such as definitions for ‘therapeutic’ and ‘non-therapeutic’
research, factors to consider in determining the best interests of
the child, the extent of information to be provided to trial
participants, how to assess a child’s understanding of research,
and how to ensure that consent is voluntary and informed; and
(v) capacity development should be provided to key
stakeholders (RECs, researchers and community advisory
boards) on the implications of the Act, including how to use
unfamiliar concepts such as the ‘best interests of the child’
standard.
The authors thank Cecilia Milford, Melissa Stobie, Nicola
Barsdorf and Graham Lindegger for comments on the article.
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